Short- and potential long-term adverse health outcomes of COVID-19: a rapid review
Autor: | Esther W. Chan, C. S. Lau, K. H. T. Wong, L. Gao, Kenneth K.C. Man, Patrick Ip, Benjamin J. Cowling, Ivan Fn Hung, M. Q. Ge, Hao Luo, A. Y. L. Chan, W. K. Leung, Kui Kai Lau, V. K. Y. Chan, Y. K. Wing, Xue Li, M. S. M. Ip, T. Y. M. Leung, C. S. M. Wong, E. Y. F. Wan, V. W. S. Ng, Ian C. K. Wong, L. K. W. Lau, Celine S L Chui, C. W. Siu |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
medicine.medical_specialty Time Factors complications Epidemiology short-term adverse outcomes Pneumonia Viral 030106 microbiology Immunology Cardiomyopathy Review Microbiology coronavirus infection Betacoronavirus 03 medical and health sciences Virology Drug Discovery Pandemic Coagulopathy health outcomes Humans Medicine Respiratory system Intensive care medicine Pandemics Stroke SARS-CoV-2 business.industry COVID-19 General Medicine medicine.disease Mental health Patient Outcome Assessment 030104 developmental biology Infectious Diseases Organ Specificity Host-Pathogen Interactions Middle East respiratory syndrome Parasitology Coronavirus Infections business long term adverse outcomes |
Zdroj: | Emerging Microbes & Infections article-version (VoR) Version of Record |
ISSN: | 2222-1751 |
DOI: | 10.1080/22221751.2020.1825914 |
Popis: | The coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of patients infected worldwide and indirectly affecting even more individuals through disruption of daily living. Long-term adverse outcomes have been reported with similar diseases from other coronaviruses, namely Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Emerging evidence suggests that COVID-19 adversely affects different systems in the human body. This review summarizes the current evidence on the short-term adverse health outcomes and assesses the risk of potential long-term adverse outcomes of COVID-19. Major adverse outcomes were found to affect different body systems: immune system (including but not limited to Guillain-Barré syndrome and paediatric inflammatory multisystem syndrome), respiratory system (lung fibrosis and pulmonary thromboembolism), cardiovascular system (cardiomyopathy and coagulopathy), neurological system (sensory dysfunction and stroke), as well as cutaneous and gastrointestinal manifestations, impaired hepatic and renal function. Mental health in patients with COVID-19 was also found to be adversely affected. The burden of caring for COVID-19 survivors is likely to be huge. Therefore, it is important for policy makers to develop comprehensive strategies in providing resources and capacity in the healthcare system. Future epidemiological studies are needed to further investigate the long-term impact on COVID-19 survivors. GRAPHICAL ABSTRACT |
Databáze: | OpenAIRE |
Externí odkaz: |